Literature DB >> 21934374

Influence of spasticity on mobility and balance in persons with multiple sclerosis.

Jacob J Sosnoff1, Eduard Gappmaier, Amy Frame, Robert W Motl.   

Abstract

BACKGROUND AND
PURPOSE: Spasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes that presumably affects mobility and balance. This investigation examined the hypothesis that persons with multiple sclerosis (MS) who have spasticity of the lower legs would have more impairment of mobility and balance compared to those without spasticity.
METHODS: Participants were 34 ambulatory persons with a definite diagnosis of MS. The expanded disability status scale (EDSS) was used to characterize disability in the study sample. All participants underwent measurements of spasticity in the gastroc-soleus muscles of both legs (modified Ashworth scale), walking speed (timed 25-foot walk), mobility (Timed Up and Go), walking endurance (6-minute walk test), self-reported impact of MS on walking ability (Multiple Sclerosis Walking Scale-12), and balance (Berg Balance Test and Activities-specific Balance Confidence Scale).
RESULTS: Fifteen participants had spasticity of the gastroc-soleus muscles based on modified Ashworth scale scores. The spasticity group had lower median EDSS scores indicating greater disability (P=0.03). Mobility and balance were significantly more impaired in the group with spasticity compared to the group without spasticity: timed 25-foot walk (P = 0.02, d = -0.74), Timed Up and Go (P = 0.01, d = -0.84), 6-minute walk test (P < 0.01, d = 1.03), Multiple Sclerosis Walking Scale-12 (P = 0.04, d = -0.76), Berg Balance Test (P = 0.02, d = -0.84) and Activities-specific Balance Confidence Scale (P = 0.04, d = -0.59). DISCUSSION AND
CONCLUSION: Spasticity in the gastroc-soleus muscles appears to have negative effect on mobility and balance in persons with MS. The relationship between spasticity and disability in persons with MS requires further exploration.

Entities:  

Mesh:

Year:  2011        PMID: 21934374     DOI: 10.1097/NPT.0b013e31822a8c40

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  30 in total

1.  Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.

Authors:  Francois A Bethoux; Dylan M Palfy; Matthew A Plow
Journal:  Int J Rehabil Res       Date:  2016-06       Impact factor: 1.479

2.  Dynamic Balance Is Related to Physiological Impairments in Persons With Multiple Sclerosis.

Authors:  Alexander T Peebles; Adam P Bruetsch; Sharon G Lynch; Jessie M Huisinga
Journal:  Arch Phys Med Rehabil       Date:  2017-12-22       Impact factor: 3.966

Review 3.  Assessment and Measurement of Spasticity in MS: State of the Evidence.

Authors:  Cinda L Hugos; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-30       Impact factor: 5.081

Review 4.  Demystifying spasticity in primary care.

Authors:  James Milligan; Kayla Ryan; Joseph Lee
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

5.  A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.

Authors:  Francois Bethoux; Ruth Ann Marrie
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

Review 6.  Comfortable walking speed and energy cost of locomotion in patients with multiple sclerosis.

Authors:  Alex Buoite Stella; Maria Elisa Morelli; Fabiola Giudici; Arianna Sartori; Paolo Manganotti; Pietro Enrico di Prampero
Journal:  Eur J Appl Physiol       Date:  2020-01-09       Impact factor: 3.078

7.  Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.

Authors:  Theodore R Kremer; Linda R Van Dillen; Joanne M Wagner
Journal:  J Rehabil Res Dev       Date:  2014

8.  Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity.

Authors:  Joanne M Wagner; Theodore R Kremer; Linda R Van Dillen; Robert T Naismith
Journal:  Arch Phys Med Rehabil       Date:  2014-02-28       Impact factor: 3.966

9.  Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).

Authors:  Uwe K Zettl; Thomas Henze; Ute Essner; Peter Flachenecker
Journal:  Eur J Health Econ       Date:  2013-12-01

10.  Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.

Authors:  Pamela Latino; Letizia Castelli; Luca Prosperini; Maria Rita Marchetti; Carlo Pozzilli; Morena Giovannelli
Journal:  Neurol Sci       Date:  2017-08-01       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.